Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Ethical issues in neurogenetic disorders
Peter B. Kang
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
6
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ethical issues in neurogenetic disorders'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Ethical Issues
100%
Neurogenetic Disorders
100%
Targeted Therapy
66%
Neurogenetics
66%
New Discovery
33%
United States
33%
Cell-based
33%
Gene Therapy
33%
Health Systems
33%
Incidental
33%
Rare Diseases
33%
Next-generation Sequencing
33%
Scientific Advances
33%
Large Population
33%
Carrier Screening
33%
Conflict of Interest
33%
Difficult Question
33%
Neurologic Disorders
33%
Cost Constraint
33%
Genetic Carrier
33%
Postmortem Genetic Testing
33%
Number of Patients
33%
Potential Conflict
33%
Expensive Therapies
33%
Medicine and Dentistry
Targeted Therapy
100%
Disease
100%
Gene Therapy
50%
Health Care Cost
50%
Cell Therapy
50%
Genetic Screening
50%
Neurologic Disease
50%
Carrier Testing
50%
Rare Disease
50%
Next Generation Sequencing
50%
Incidental Finding
50%
Diseases
50%
Neuroscience
Vigilance
100%
Face
100%
Cell Therapy
100%
Biochemistry, Genetics and Molecular Biology
Neurogenetics
100%
Gene Therapy
20%
Next Generation Sequencing
20%
Genetic Screening
20%